Clinical Trial Update: The Effects of Omega-3 Fatty Acids on Metabolic Syndrome [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating the effects of omega-3 fatty acids on metabolic syndrome, sponsored by the University of Washington.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Washington | Conditions: Metabolic Syndrome X | EARLY_Phase 1 | Status: UNKNOWN